proflavine has been researched along with Disease Models, Animal in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chierici, S; Demeunynck, M; Dubois-Dauphin, M; Garin, D; Ghezzi, C; Gözel, B; Laferla, FM; Marti-Battle, D; Meyronet, D; Millet, P; Oukhatar, F; Perret, P; Sallanon Moulin, M; Streichenberger, N; Touret, M; Virgone-Carlotta, A | 1 |
| Chierici, S; Demeunynck, M; Dubois-Dauphin, M; Garin, D; Laferla, FM; Mahon, AB; Oukhatar, F; Sallanon, MM; Try, AC | 1 |
2 other study(ies) available for proflavine and Disease Models, Animal
| Article | Year |
|---|---|
COB231 targets amyloid plaques in post-mortem human brain tissue and in an Alzheimer mouse model.
Topics: Alzheimer Disease; Aminacrine; Animals; Autopsy; Brain; Disease Models, Animal; Female; Fluorescent Dyes; Humans; Image Processing, Computer-Assisted; Immunohistochemistry; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microscopy, Fluorescence; Plaque, Amyloid; Proflavine; Sensitivity and Specificity; Staining and Labeling | 2015 |
Proflavine derivatives as fluorescent imaging agents of amyloid deposits.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Disease Models, Animal; Fluorescent Dyes; Mice; Mice, Transgenic; Microscopy, Fluorescence; Peptide Fragments; Plaque, Amyloid; Proflavine | 2011 |